Edding Genor Group Holdings (HKSE:06998) Enterprise Value: HK$3,483 Mil (As of Aug. 27, 2026) ***

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:06998 Edding Genor Group Holdings Ltd HKSE:06998
15 GF Score
Price HK$1.53
! 1 Warning Sign
View Full Analysis

What is Edding Genor Group Holdings Enterprise Value?

Edding Genor Group Holdings HKSE:06998 +0.33% 15 Enterprise Value is HK$3,483 Mil as of Aug. 27, 2026. GuruFocus rates HKSE:06998 with a GF Score™ of 15/100. The stock has 1 warning sign investors should review.

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Edding Genor Group Holdings's Enterprise Value is HK$3,483 Mil. Edding Genor Group Holdings does not have enough years/quarters to calculate its EBIT for the trailing twelve months (TTM) ended in Dec. 2025. Therefore, GuruFocus does not calculate Edding Genor Group Holdings's EV-to-EBIT at this moment.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Edding Genor Group Holdings's Enterprise Value is HK$3,483 Mil. Edding Genor Group Holdings does not have enough years/quarters to calculate its EBITDA for the trailing twelve months (TTM) ended in Dec. 2025. Therefore, GuruFocus does not calculate Edding Genor Group Holdings's EV-to-EBITDA at this moment.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Edding Genor Group Holdings's Enterprise Value is HK$3,483 Mil. Edding Genor Group Holdings does not have enough years/quarters to calculate its Revenue for the trailing twelve months (TTM) ended in Dec. 2025. Therefore, GuruFocus does not calculate Edding Genor Group Holdings's EV-to-Revenue at this moment.

EV-to-OCF is calculated as Enterprise Value divided by its Cash Flow from Operations. As of today, Edding Genor Group Holdings's Enterprise Value is HK$3,483 Mil. Edding Genor Group Holdings does not have enough years/quarters to calculate its Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025. Therefore, GuruFocus does not calculate Edding Genor Group Holdings's EV-to-OCF at this moment.

EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Edding Genor Group Holdings's Enterprise Value is HK$3,483 Mil. Edding Genor Group Holdings does not have enough years/quarters to calculate its Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025. Therefore, GuruFocus does not calculate Edding Genor Group Holdings's EV-to-FCF at this moment.

*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.


Edding Genor Group Holdings  (HKSE:06998) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.


Edding Genor Group Holdings Enterprise Value Related Terms


Edding Genor Group Holdings Enterprise Value Historical Data

* Premium members only.

The historical data trend for Edding Genor Group Holdings's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Edding Genor Group Holdings Enterprise Value Chart

Edding Genor Group Holdings Annual Data
Trend Dec24 Dec25
Enterprise Value
0.00 0.00

Edding Genor Group Holdings Semi-Annual Data
Dec24 Dec25
Enterprise Value 0.00 0.00

HKSE:06998 vs ZTS: Enterprise Value Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Edding Genor Group Holdings's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Edding Genor Group Holdings Enterprise Value vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Edding Genor Group Holdings's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Edding Genor Group Holdings's Enterprise Value falls into.


HKSE:06998
15GF Score
Edding Genor Group Holdings Ltd HKSE:06998
Enterprise Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Edding Genor Group Holdings Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Edding Genor Group Holdings's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as

Edding Genor Group Holdings's Enterprise Value for the quarter that ended in Dec. 2025 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Enterprise Value →
What does a Enterprise Value of HK$3,483 Mil mean?
Edding Genor Group Holdings (HKSE:06998) has a Enterprise Value of HK$3,483 Mil as of Aug. 27, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Edding Genor Group Holdings and its competitors.
Is Edding Genor Group Holdings' Enterprise Value too high?
Edding Genor Group Holdings' current Enterprise Value is HK$3,483 Mil. Overall, Edding Genor Group Holdings has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Edding Genor Group Holdings' Enterprise Value compare to ZTS?
Edding Genor Group Holdings' Enterprise Value of HK$3,483 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Drug Manufacturers company?
A good Enterprise Value depends on the Drug Manufacturers industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Edding Genor Group Holdings and its competitors. Edding Genor Group Holdings's current Enterprise Value is HK$3,483 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Edding Genor Group Holdings stock overvalued right now?
Edding Genor Group Holdings (HKSE:06998) has a current Enterprise Value of HK$3,483 Mil. The current Enterprise Value is HK$3,483 Mil. Edding Genor Group Holdings' overall GF Score™ is 15/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Edding Genor Group Holdings (HKSE:06998), the current Enterprise Value is HK$3,483 Mil as of Aug. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Edding Genor Group Holdings Business Description

Address No. 36 Doukou Road, Room 406, Building 1, Hengqin New Area, Guangdong Province, Zhuhai, CHN
Edding Genor Group Holdings Ltd is an integrated specialty biopharmaceutical company, focusing on oncology, autoimmune diseases, cardiovascular diseases, respiratory diseases, and anti-infectives. Through the acquisition of branded drug assets from multinational pharmaceutical companies (MNCs) and licensing in development and commercialisation rights of patented drugs from international biopharmaceutical companies, it has established a portfolio of originator-branded and other drugs. The company has two reportable operating segments: Manufacturing and Distribution, which generates the maximum revenue, and Research and development. Geographically, it derives maximum revenue from the Chinese mainland, and the rest from the USA and other markets.
15GF Score

Get the complete analysis for HKSE:06998

Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$1.53
Price